Đang chuẩn bị liên kết để tải về tài liệu:
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Recently, the prognostic significance of circulating tumor cells (CTCs) in primary breast cancer as assessed using the Food-and-Drug-Administration-approved CellSearch® system has been demonstrated. |

TÀI LIỆU LIÊN QUAN

Quantitative detection of circulating nucleophosmin mutations DNA in the plasma of patients with acute myeloid leukemia

Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDRqPCR assay for breast cancer detection

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: A systematic mapping review

Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients

Novel approaches in cancer management with circulating tumor cell clusters

Diagnostic accuracy of circulating tumor cells detection in gastric cancer: Systematic review and meta-analysis

Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma

Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): A study protocol for a prospective, multicentre trial

Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma